![]() |
Volumn 112, Issue 13, 2008, Pages 4785-4786
|
The yin and yang of lenalidomide
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
CD20 ANTIBODY;
CD23 ANTIGEN;
CD38 ANTIGEN;
IMMUNOLIPOSOME;
IMMUNOMODULATING AGENT;
LENALIDOMIDE;
MICRORNA;
RITUXIMAB;
SMALL INTERFERING RNA;
THALIDOMIDE;
ANTIANGIOGENIC ACTIVITY;
APOPTOSIS;
B LYMPHOCYTE;
CELL FUNCTION;
CELL KILLING;
CHINESE MEDICINE;
CHRONIC LYMPHATIC LEUKEMIA;
CYTOTOXICITY;
DOWN REGULATION;
HUMAN;
LEUKEMIA CELL;
MULTIPLE MYELOMA;
MYELODYSPLASTIC SYNDROME;
NATURAL KILLER CELL;
NEUROTOXICITY;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
|
EID: 61849086801
PISSN: 00064971
EISSN: 15280020
Source Type: Journal
DOI: 10.1182/blood-2008-09-180265 Document Type: Note |
Times cited : (1)
|
References (5)
|